Eaton Vance Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
Other funds holding LUMO
NMC
JG
LPC
Eaton Vance Management's LUMO Position: Q1 2022 in Review
Eaton Vance Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2022, closing a stake of 58 shares.
Eaton Vance Management first reported a position in LUMO in Q1 2021 and held it in 4 quarters. The position peaked at $1K in Q3 2021. 36 funds tracked by Wall St. Rank hold LUMO as of Q1 2022.
- Eaton Vance Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- Eaton Vance Management sold 58 Lumos Pharma, Inc. Common Stock shares in Q1 2022.
- Eaton Vance Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
- Eaton Vance Management's Lumos Pharma, Inc. Common Stock position peaked at $1K in Q3 2021.
- 36 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2022.
Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.